Belimumab
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB08879 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 40 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary release disorder of platelets | KG + DL |
| 2 | pseudo-von Willebrand disease | KG + DL |
| 3 | Glanzmann thrombasthenia | KG + DL |
| 4 | fetal and neonatal alloimmune thrombocytopenia | KG + DL |
| 5 | severe nonproliferative diabetic retinopathy | KG + DL |
| 6 | autosomal dominant macrothrombocytopenia | KG + DL |
| 7 | granulomatous disease, chronic, autosomal recessive, 5 | KG + DL |
| 8 | anus disease | KG + DL |
| 9 | inflammatory bowel disease | KG + DL |
| 10 | granulomatous disease with defect in neutrophil chemotaxis | KG + DL |
| 11 | Scott syndrome | KG + DL |
| 12 | functional neutrophil defect | KG + DL |
| 13 | congenital hypotrichosis with juvenile macular dystrophy | KG + DL |
| 14 | systemic sclerosis | KG + DL |
| 15 | psoriasis | KG + DL |
| 16 | bleeding diathesis due to a collagen receptor defect | KG + DL |
| 17 | hemorrhagic disorder due to a constitutional thrombocytopenia | KG + DL |
| 18 | Crohn disease of the esophagus | KG + DL |
| 19 | ulcerative colitis (disease) | KG + DL |
| 20 | cyclic hematopoiesis | KG + DL |
| 21 | platelet-type bleeding disorder | KG + DL |
| 22 | adult idiopathic neutropenia | KG + DL |
| 23 | X-linked severe congenital neutropenia | KG + DL |
| 24 | Ehlers-Danlos syndrome, fibronectinemic type | KG + DL |
| 25 | peeling skin syndrome | KG + DL |
| 26 | pityriasis lichenoides | KG + DL |
| 27 | congenital neutropenia-myelofibrosis-nephromegaly syndrome | KG + DL |
| 28 | autosomal recessive severe congenital neutropenia due to JAGN1 deficiency | KG + DL |
| 29 | autosomal recessive severe congenital neutropenia due to CSF3R deficiency | KG + DL |
| 30 | parapsoriasis | KG + DL |
| 31 | diabetic retinopathy | KG + DL |
| 32 | psoriasis 14, pustular | KG + DL |
| 33 | C1 inhibitor deficiency | KG + DL |
| 34 | autosomal recessive severe congenital neutropenia due to CXCR2 deficiency | KG + DL |
| 35 | pustulosis palmaris et plantaris | KG + DL |
| 36 | acute lichenoid pityriasis | KG + DL |
| 37 | serpinopathy with toxic serpin polymerization | KG + DL |
| 38 | Peyronie disease | KG + DL |
| 39 | thrombotic thrombocytopenic purpura | KG + DL |
| 40 | heparin cofactor 2 deficiency | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.